Nonwoven Surgical Drapes Market size is set to gain momentum over 2023-2032, on account of the increasing risk of cardiovascular diseases, especially in the United States. The substantial rise in disease burden is highlighting the need for equitable access to treatments and surgeries. Another key factor leading to robust demand for nonwoven sterile surgical drapes is the mounting number of cesarean procedures worldwide.
Based on data from Eurostat, in 2020, between 200 and 400 cesarean section surgeries were conducted per 100,000 inhabitants in most of the EU Member States. This acceleration of surgical procedures is projected to boost the development of medical drapes to ensure safety and prevent wound infections among patients.
Nonwoven surgical drapes are sterile coverings utilized during surgery to limit contact with unprepared surfaces and keep the medical equipment and patient surroundings as sterile as possible. The production of low-cost goods is a major factor promoting the use of nonwoven textiles in medical applications. Attributes such as breathability and barrier against body fluids, blood, and other contaminants are also boosting the demand for nonwoven materials in surgical drape manufacturing.
The use of nonwoven medical items has become a major priority for government organizations such as the U.S. Department of Health and Human Services to limit HAIs. Over the years, musculoskeletal conditions have emerged as a contributor to disability. Based on the Center for Orthopaedic Surgery and Sports Medicine, 24% of the adult population is diagnosed with arthritis in the U.S. These factors will stimulate the rate of orthopedic surgeries and consequently bolster the consumption of surgical drapes and gowns.
Laparoscopy drapes are set to become a profitable product segment for the nonwoven surgical drapes market by 2032, owing to the shifting preference toward minimally invasive surgeries. The cases of heart attacks are growing dramatically, mainly due to the adoption of sedentary lifestyles. As per the WHO’s report, cardiovascular diseases account for nearly 45% of deaths among adults aged 40 to 69 years of age in India, amplifying the demand for laparoscopic heart surgeries. The extensive availability of impermeable, safe, and efficient drapes to prevent microbial transfer during laparoscopic surgeries will foster market trends in the upcoming years.
Based on the application, the cardiac surgery segment will account for a considerable share of the nonwoven surgical drapes market over the forecast period, owing to the rising number of heart transplants. Based on the Organ Procurement & Transplantation Network’s statistics, in 2020, over 3,658 heart transplants were conducted in the U.S. The risk of stroke and heart failure has also substantially increased among people who have recovered from the COVID-19 disease. These factors, alongside the increasing burden of cardiovascular diseases, will proliferate the use of nonwoven surgical drapes for cardiac surgery applications.
Regionally, the Middle East and Africa nonwoven surgical drapes market is expected to amass considerable profits from 2023 to 2032, due to the expansion of ambulatory surgical centers. For example, in November 2022, Mubadala Health opened a surgery and outpatient clinic in Dubai to provide multidisciplinary pediatric, medical, and surgical specialties including cardiology and orthopedics. Additionally, cases of heart disease are on the rise among youth in the UAE, further bolstering product development in MEA countries.
Prominent companies operating in the nonwoven surgical drapes market include Mölnlycke Health Care AB, STERIS Corporation, Halyard Health, Medline Industries, LP, PAUL HARTMANN AG, Medica Europe BV, Cardinal Health, and 3M, among others. These firms are focusing on new product launches and other initiatives to strengthen their market presence. For instance, in March 2022, Cardinal Health launched a surgical incise drape with the use of antiseptic Chlorhexidine Gluconate, designed to reduce the risk of surgical site contamination.
Inflation continues to impact healthcare organizations in multiple ways, including patient care decisions. As per survey data from the Institute for Healthcare Policy and Innovation of the University of Michigan, 46% of the respondents revealed that out-of-pocket costs were a major concern leading patients to opt out of surgeries. Significant financial losses due to missed elective procedures are thus likely to limit the adoption nonwoven surgical equipment drape over the forthcoming years.